Cyclic ADP-ribose (cADPR), an endogenous metabolite of nicotinamide adenine dinucleotide, was first reported to be present in sea urchin eggs and to possess Ca 2ϩ mobilizing activity (Clapper et al., 1987; Lee et al., 1989) . Recent studies have indicated that cADPR is produced in a variety of mammalian tissues and cells, including heart, liver, spleen, brain and red blood cells, pituitary cells, as well as renal epithelial cells (Beers et al., 1995; Koshiyama et al., 1991; Takesawa et al., 1993; White et al., 1993) . Basal concentrations of cADPR in cardiac muscle, liver, and brain are estimated to be 100 -200 nM (Galione, 1994; Lee, 1994) . Like sea urchin eggs, cADPR also causes Ca 2ϩ release from the endoplasmic reticulum in these mammalian tissues and cells. It mobilizes intracellular Ca 2ϩ by a mechanism completely independent of inositol 1,4,5-trisphosphate (IP 3 ), since the IP 3 receptor antagonist heparin cannot block the effect of cADPR (Galione, 1994; Galione et al., 1993; Aarhus, 1991, 1993) . This cADPR-induced Ca 2ϩ release may mediate the secretion of hormones such as insulin and catecholamines, the fertilization of eggs, the estrogen response in rat uterus, and the effects of nitric oxide (NO), serotonin, and acetylcholine in nonmuscle tissues (Chini et al., 1997; Galione, 1993; Galione et al., 1993; Lee, 1993; Aarhus, 1991, 1993; Lee et al., 1989; Morita et al., 1997; Takesawa et al., 1993) .
There are two major Ca 2ϩ release mechanisms in excitable and nonexcitable mammalian cells: one dependent on the second messenger IP 3 and another sensitive to Ca 2ϩ and known as calcium-induced calcium release (CICR) (Berridge, 1997) . Recent studies have indicated that inhibitors of CICR, such as tetracaine, ryanodine, and ruthenium red, selectively inhibit cADPR-sensitive Ca 2ϩ release and agonists of CICR, such as caffeine and Ca 2ϩ , potentiate the Ca 2ϩ releasing activity of cADPR Lee, 1993 Lee, , 1994 Lee et al., 1995) , indicating that cADPR may be a novel endogenous Ca 2ϩ mobilizing molecule mediating or modulating CICR. However, this role of cADPR in CICR has not yet been studied in vascular smooth muscle cells. Recently, studies in our laboratory and by others have demonstrated that cADPR can be produced in coronary arterial smooth muscles and that cADPR activates reconstituted ryanodine receptors (RyR) and induces Ca 2ϩ release from intracellular stores of these coronary myocytes (Kannan et al., 1996; Li et al., 1998 Li et al., , 2001 Yu et al., 2000) . It remains unknown whether the effect of cADPR is attributed to CICR in vascular smooth muscle cells and whether cADPR-or RyR-mediated CICR plays an important role in the vasomotor response of these arteries. The present study was designed to test the hypothesis that cADPR-and RyR-mediated CICR is functioning in coronary arterial smooth muscle cells, which contributes to the control of intercellular Ca 2ϩ concentrations and vasoconstrictor response in these vessels. We first determined the role of CICR in KCl-and caffeine-induced [Ca 2ϩ ] i increase in coronary arterial smooth muscle cells using single cell fluorescent microscopic spectrometry and then examined the contribution of CICR to the KCl-induced contractile response in isolated and pressurized small coronary arteries. By measuring the Ca 2ϩ release response in single coronary myocytes and the contractile response to KCl, we also examined the role that cADPR plays in CICR of these coronary arteries.
MATERIALS AND METHODS

Isolation of coronary arterial smooth muscle cells (CASMCs).
The small coronary arteries (200 -500 m i.d.) from fresh bovine hearts were dissected and pooled. The arterial segments were incubated for 10 min at room temperature (RT) in dissociation solution containing (mM) NaCl, 145; KCl, 5.6; CaCl 2 , 0.05; MgCl 2 , 1; NaHCO 3 , 4.2; glucose, 10; and Hepes, 10, and in albumin, 1 mg/ml (pH 7.4). The segments were then incubated for 30 min at 37°C in 1 ml of dissociation solution containing 1.5 mg/ml of papain and 1 mg/ml of dithiothreitol, followed by an incubation for 30 min at 37°C in 1 ml of dissociation solution containing 2 mg/ml of collagenase, 0.5 mg/ml of elastase, and 1 mg/ml of soybean trypsin inhibitor. The supernatant was collected and the cells were spun down at 500g for 5 min, resuspended in fresh dissociation solution, and stored at 4°C until used.
Measurement of [Ca 2؉ ] i in CASMCs. Fura2-AM (Molecular Probes) was used for monitoring intracellular [Ca 2ϩ ] i (Tsien, 1989 
, where the R was a fluorescence ratio of fura-2 excited at 340 and 380 nm and recorded at 510 nm (F 340 /F 380 ), R max and R min were the fluorescence ratios determined by adding 2 M ionomycin (saturating Ca 2ϩ ) and subsequently adding 2 mM EGTA (zero Ca 2ϩ ), respectively, F 0 and F S were the maximal (zero Ca 2ϩ ) and minimal (saturating Ca 2ϩ ) signal intensities at 380 nm, respectively, and K d was the dissociation constant of fura-2 for Ca 2ϩ , assumed to be 224 nM (Tsien, 1989) . Intracellular Ca 2ϩ release from the intracellular store was stimulated by adding KCl (80 mM) or caffeine (1 mM) into the bath solution 15 min after incubation of the cells in Ca 2ϩ -free Hanks' buffer consisting of (mM) NaCl, 130; KCl, 5.4; EGTA, 1; glucose, 5.5; and Hepes, 20, pH 7.4 . To study the effects of CICR modulators on this calcium release, ryanodine (50 M) or tetracaine (50 M), two CICR inhibitors (Gyorke and Palade, 1992; Li et al., 2001; Venosa and Hoya, 1999) , thapsigargin (2 M), a Ca 2ϩ -ATPase inhibitor (Gonzales et al., 1995) , xestospongin (2 M), an IP 3 receptor blocker (Bishara et al., 2001; Gafni et al., 1997) , or 8-bromocADP-ribose (30 M), a cell permeable cADPR antagonist (Lee, 1994) , was added into the bath solution 10 min before caffeine-or KCl-induced Ca 2ϩ release was determined.
Isolated small coronary artery preparation. Fresh bovine hearts were obtained from a local abattoir. Small intramural coronary arteries from the left anterior descending artery were carefully dissected. Segments of small arteries (100 -200 m i.d.) were cannulated with two glass micropipettes as described previously (Zhang et al., 2001) . The outflow cannula was clamped, and the arteries were pressurized to 60 mm Hg. The arteries were bathed in the PSS containing (mM) NaCl, 119; KCl, 4.7; CaCl 2 , 1.6; MgSO 4 , 1.17; NaH 2 PO 4 , 1.18; NaHCO 3 , 24; EDTA, 0.026; and glucose, 5.5, pH 7.4, equilibrated with 95% O 2 /5% CO 2 , and maintained at 37°C. The vasoconstrictor or vasodilator responses were determined based on changes in the internal diameter.
To determine the role of CICR in the development of basal vascular tone, the arteries were incubated with Bay K 8644 (2 nM), a Ca 2ϩ channel agonist, to elicit an optimal basal tone (10 -15% decrease in internal diameter). Then, the responses to ryanodine (10 -50 M) or tetracaine (10 -50 M) were examined. To determine the role of CICR in agonist-induced contraction, the arteries were pretreated with ryanodine (50 M), tetracaine (50 M), xestospongin (2 M), 8-bromo-cADPribose (30 M, 8-br-cADPR), or vehicle for 20 min before the contractile response to KCl (40 mM) was examined. As a control, the contractile responses to U46619 (100 nM) were examined before and after the treatment of the arteries with xestospongin (2 M) for 15 min. U46619, a thromboxane A 2 analogue, has been reported to produce vasoconstriction through increase in intracellular IP 3 concentration and/or opening of the membrane Ca 2ϩ channels (Tosun et al., 1998; Yamagishi et al., 1992) .
Statistics. Data are presented as means Ϯ SEM. The significance of differences in mean values between and within multiple groups was examined using an analysis of variance for repeated measures followed by Duncan's multiple range test (Sigmastat). Student's t test was used to evaluate the significance of differences between two paired observations. P Ͻ 0.05 was considered statistically significant. (Katsuyama et al., 1991; Mellors et al., 1999) , while the sustained increase in [Ca 2ϩ ] i corresponded to Ca 2ϩ influx (Ethier et al., 2001; Fukao et al., 2001; Liu et al., 2001; Yu et al., 2000) . Therefore, the peak increase in this Ca 2ϩ transient was calculated as the Ca 2ϩ release from SR. To determine whether CICR participates in this KCl-induced Ca 2ϩ release response, the cells were pretreated with the specific CICR inhibitor ryanodine (50 M) or tetracaine (50 M) for 20 min. In the presence of these inhibitors, the KCl-induced Ca 2ϩ release was significantly attenuated, but the sustained increase in [Ca 2ϩ ] i still exhibited. Figure 1B summarizes the effects of these inhibitors on KCl-induced Ca 2ϩ release in CASMCs. Ryanodine and tetracaine inhibited the increase in [Ca 2ϩ ] i induced by KCl to 279 Ϯ 75 and 304 Ϯ 69 nM, which were much lower than the increase of 533 Ϯ 77 nM in controls.
RESULTS
Effects of ryanodine and tetracaine on
The changes in [Ca 2ϩ ] i induced by the CICR activator caffeine in CASMCs are shown in Fig. 2 in response to KCl in the absence or the presence of Rya or TC (n ϭ 9). *P Ͻ 0.05 vs control.
shown). When the cells were pretreated with ryanodine (50 M) or tetracaine (50 M), caffeine-induced Ca 2ϩ release was also significantly blocked. As summarized in Fig. 2B , caffeine produced a peak increase in [Ca 2ϩ ] i by 495 Ϯ 77 nM in controls, but only by 89 Ϯ 52 and 192 Ϯ 93 nM in the presence of ryanodine and tetracaine, respectively.
Effect of xestospongin on KCl-and caffeine-induced Ca 2؉ release in CASMCs. To examine whether KCland caffeine-induced Ca 2ϩ release is also related to the IP 3 pathway, the cells were pretreated with xestospongin (2 M, for 20 min), an IP 3 antagonist. It was found that xestospongin had no significant effect on the increase in [Ca 2ϩ ] i induced by KCl (80 mM) and caffeine (1 mM) (Fig. 3) Role of CICR in the development of vascular tone in small coronary arteries. The average resting diameter of six pressurized small bovine coronary arteries averaged 120 Ϯ 15 m. Addition of deta NONOate (100 M), an NO donor, increased the arterial diameter to 149 Ϯ 17 m, indicating the presence of basal vascular tone in these arteries. Using these arterial preparations, the role of CICR in the development of basal vascular tone was determined. Ryanodine (10 -50 M) or tetracaine (10 -50 M) resulted in a dose-dependent vasodilation in these arteries. The maximal increases in arterial diameter were 10 Ϯ 2 and 11 Ϯ 2% in the presence of ryanodine and tetracaine, respectively.
Role of CICR in KCl-induced contraction in small coronary arteries. The effects of CICR inhibitors on KCl-induced contractile response of small bovine coronary arteries are shown in Fig. 5 . Figure 5A presents the representative video recordings of the arteries under control conditions or after treatment with KCl, ryanodine ϩ KCl, or tetracaine ϩ KCl. As summarized in Fig. 5B , KCl (40 mM) alone contracted the arteries by 64 Ϯ 11% relative to resting controls. After incubation of arteries with the CICR inhibitor ryanodine (50 M) or tetracaine (50 M) for 20 min, the contractile responses to KCl were significantly inhibited, with maximal contractions of 41 Ϯ 11 and 35 Ϯ 6%, respectively. Corresponding to the results of Ca 2ϩ measurement described above, pretreatment of the arteries with the IP 3 inhibitor xestospongin (2 M, for 20 min) had no effect on KCl-induced contraction. Xestospongin also had no significant effect on the basal vascular tone. However, it markedly attenuated the contraction induced by U46619, an agonist known to act through the IP 3 pathway (Fig. 5C) .
Effect of 8-bromo-cADP-ribose on KCl-induced Ca 2؉ release in CASMCs and contraction in small coronary arteries. All of the above experiments indicate that KCl-induced Ca 2ϩ release in CASMCs and contraction in small bovine coronary arteries is at least partially mediated by RyR-mediated CICR. However, the mechanism by which KCl activates the CICR has yet to be determined. Because cADPR can activate the RyR and modulate the CICR, a selective cADPR antagonist, 8-br-cADPR, was used to determine whether the Ca 2ϩ release and contraction induced by KCl was dependent on the action of cADPR. As shown in Fig.   FIG. 5 . Effect of Rya, TC, and XeC on KCl-or U46619-induced contractile responses in isolated small coronary arteries. (A) Representative video prints of the arteries under control conditions or after treatment with KCl, ryanodine ϩ KCl, or tetracaine ϩ KCl. (B and C) Summarized data showing that the vasoconstriction in response to KCl (40 mM) (n ϭ 6) or U46619 (100 nM) (n ϭ 6) were determined under control conditions or after pretreatment with Rya (50 M), TC (50 M), or XeC (2 M). *P Ͻ 0.05 vs control.
6A, 8-br-cADPR (30 M) significantly inhibited the increase in [Ca 2ϩ ] i induced by KCl (80 mM) in CASMCs to a similar extent to ryanodine and tetracaine. The KCl-induced Ca 2ϩ increases were decreased to 246 Ϯ 77 nM after pretreatment of arteries with 8-br-cADPR. In isolated and perfused small coronary arteries, 8-br-cADPR pretreatment also significantly attenuated the contraction induced by KCl (40 mM) (Fig. 6B) .
DISCUSSION
In the present study, we found that both KCl and caffeine induced a rapid increase in [Ca 2ϩ ] i in freshly dissociated myocytes from small resistance coronary arteries, which was significantly inhibited by the CICR inhibitors ryanodine and tetracaine, but not by the IP 3 antagonist xestospongin. Blockade of CICR decreased the resting tone and attenuated KCl-induced contraction in pressurized small coronary arteries. Inhibition of cADPR actions by 8-br-cADPR also significantly blocked KCl-induced increase in [Ca 2ϩ ] i and contractile response in these arteries. These results indicate that CICR-and cADPR-mediated Ca 2ϩ signaling are involved in the control of [Ca 2ϩ ] i in small coronary arterial smooth muscle and thereby contribute to vasoconstrictor response in these arteries.
A variety of agonists, such as norepinephrine, acetylcholine, and ATP, have been reported to mobilize Ca 2ϩ from the SR through the IP 3 -mediated signaling pathway in vascular smooth muscles (Kobayashi et al., 1988 (Kobayashi et al., , 1989 Mellors et al., 1999; Somlyo et al., 1985; Utz et al., 1999) . However, the mechanisms by which other stimuli, such as membrane depolarization, Ca 2ϩ influx, and some vasoactive agonists like endothelin, induce Ca 2ϩ mobilization remain unknown. In the first series of experiments, we determined whether KCl-induced Ca 2ϩ mobilization is associated with CICR in CASMCs. Using fluorescent microscopic spectrometry, KCl was found to induce an intracellular Ca 2ϩ transient response that consisted of a rapid peak increase in [Ca 2ϩ ] i followed by a sustained rise in [Ca 2ϩ ] i , which represent the Ca 2ϩ release and influx, respectively (Ethier et al., 2001; Fukao et al., 2001; Katsuyama et al., 1991; Liu et al., 2001; Mellors et al., 1999) . Therefore, the present study observed both Ca 2ϩ influx and Ca 2ϩ release in CASMCs when KCl was added into the bath. Since the Ca 2ϩ release was activated by the membrane depolarization and the subsequent entry of Ca 2ϩ into the cells, it represented a Ca 2ϩ influx-induced Ca 2ϩ release. In the presence of the RyR blocker ryanodine and the CICR inhibitor tetracaine, the KCl-induced rapid peak increase in [Ca 2ϩ ] i was substantially attenuated, while xestospongin was without effect on this KClinduced peak Ca 2ϩ increase. These results suggest that KCl-induced Ca 2ϩ release is primarily from a ryanodine-sensitive but not IP 3 -sensitive Ca 2ϩ store and this Ca 2ϩ release represents CICR. Furthermore, the present study demonstrated that depletion of the SR Ca 2ϩ store by thapsigargin significantly decreased the KCl-induced peak increase in [Ca 2ϩ ] i , confirming that KCl-induced Ca 2ϩ release is from the Ca 2ϩ -ATPaserelated Ca 2ϩ store in the SR. To further confirm that CICR is functioning in CASMCs, caffeine, a well-characterized CICR activator (Hurley et al., 1999; Janiak et al., 2001) , was employed to characterize this Ca 2ϩ signaling mechanism in the present study. As expected, caffeine primarily produced a rapid Ca 2ϩ release response in CASMCs, which was markedly blocked by ryanodine, tetracaine, and thapsigargin, but not by xestospongin. Taking these results together, we conclude that CICR is functioning in CASMCs, which can be activated by membrane depolarization and consequent Ca 2ϩ influx as well as direct binding of caffeine to RyR. This CICR in CASMCs is associated with activation of RyR, rather than IP 3 receptors on the SR and is sensitive to Ca 2ϩ -ATPase inhibition.
To determine the physiological importance of this CICR in the control of vascular tone, the effects of CICR antagonists on the basal vascular tone and vasomotor reactivity were examined using an isolated and pressurized small coronary arterial preparation. Ryanodine and tetracaine were found to produce a dose-dependent vasodilation in these small coronary arteries. Pretreatment of the arteries with CICR antagonists significantly attenuated the vasoconstrictor response to KCl. In contrast, the IP 3 inhibitor xestospongin had no effect on KCl-induced vasoconstriction, but decreased the vasoconstrictor response to U46619, a vasoactive agent known to act through the IP 3 pathway (Tosun et al., 1998; Yamagishi et al., 1992) . These results provide direct evidence that RyR-mediated CICR is involved in the development of basal vascular tone and the vasoconstrictor response in small coronary arteries. This finding is generally in agreement with previous reports indicating that RyR participates in the regulation of the vascular tone under basal conditions and after stimulation in other vascular beds, such as aorta and cerebral and pulmonary arteries (Ito et al., 1991; Kamishima and McCarron, 1997; Vandier et al., 1997; Watanabe et al., 1993) . Based on these findings, we propose that under the resting conditions, a small Ca 2ϩ influx may produce Ca 2ϩ release through RyR-mediated CICR, thereby developing basal vascular tone in these coronary arteries. When the cell membrane is depolarized and Ca 2ϩ influx largely increased, a remarkable CICR would be activated, resulting in vasoconstriction. This CICR-mediated vasomotor response may represent another important mechanism to mediate the effects of vasoactive agents or other stimuli independent of the IP 3 pathway.
Previous studies have indicated that the Ca 2ϩ signal induced by membrane influx may be attenuated by the SR Ca 2ϩ uptake or accumulation. It seems that Ca 2ϩ influx should not produce Ca 2ϩ release in this type of myocytes (van Breemen et al., 1995) . However, recent studies demonstrate that the buffering of Ca 2ϩ entry by the SR occurs mainly if there is a more gradual buildup of [Ca 2ϩ ] i resulting from a moderate stimulation of Ca 2ϩ entry in the SR close to the cell membrane. When [Ca 2ϩ ] i rapidly increases in the vicinity of RyR on the SR, a Ca 2ϩ release amplification response by CICR can be produced in vascular smooth muscle cells (van Breemen et al., 1995) . It is obvious that the role of CICR or superficial SR Ca 2ϩ buffering in the regulation of [Ca 2ϩ ] i depends upon the magnitude and speed of Ca 2ϩ influx. There is substantial evidence that a large Ca 2ϩ influx primarily produces CICR, especially in small arteries or arterioles (Ganitkevich and Isenberg, 1995; Kamishima and McCarron, 1997, 1998 The next question we tried to answer was whether there is an endogenous mediator or modulator which is involved in CICR. Recent studies in our laboratory have shown that an enzyme pathway responsible for cADPR production and hydrolysis is present in coronary arterial smooth muscle cells (Li et al., 1998) . We wondered whether cADPR participates in CICR and thereby plays a role in the control of vascular tone. To address this question, we performed another series of experiments to examine the effects of a specific cell permeable cADPR antagonist, 8-br-CADPR, on CICR and CICR-related vasomotor responses in small coronary arteries. We found that blockade of cADPR actions by 8-br-cADPR significantly attenuated the Ca 2ϩ release induced by KCl in single CASMCs and the vasoconstrictor response to KCl in pressurized small coronary arteries. These results support the view that cADPR participates in the regulation of vascular tone through a CICR mechanism in these small coronary arteries. This is consistent with the our previous report showing that the inhibition of cADPR formation produces vasorelaxation and blunts Bay-K8644-induced vasoconstriction using bovine large coronary artery ring preparations (Geiger et al., 2000) .
The mechanism by which cADPR affects the CICR and vascular tone in coronary arteries remains unknown. However, two mechanistic models of cADPR action in smooth muscle cells and other cells have been proposed recently, including cADPR as mediator or modulator of CICR (Galione et al., 1998; Lee et al., 1995) . As mediators, it is assumed that the agonists or stimuli induce the activation of ADP-ribosyl cyclase, an enzyme responsible for the production of cADPR from NAD, leading to an increase in the cytosolic cADPR and a subsequent activation of RyR-mediated Ca 2ϩ release. In addition, intracellular Ca 2ϩ increase may also activate the production of cADPR, thereby resulting in Ca 2ϩ release. As a modulator, the cytosolic cADPR sensitizes the RyR, enhancing CICR activated by agonists or Ca 2ϩ influx. The relative contribution of these two mechanisms may vary depending on the concentrations of intracellular cADPR, Ca 2ϩ , and calmodulin and RyR functional status in different cells. Although the present study demonstrated that cADPR is involved in CICR in coronary arterial myocytes, it remains unknown whether it serves as a mediator or modulator or both in these cells. Further studies are needed to clarify this issue when a validated measurement of cADPR concentrations is available.
In summary, the present study demonstrated that KCl and caffeine induced Ca 2ϩ release from intracellular stores of coronary arterial smooth muscle cells and this Ca 2ϩ release was decreased in the presence of CICR and cADPR antagonists. Corresponding to these effects in single myocytes, inhibition of CICR or blockade of cADPR action induced vasorelaxation and attenuated the vasoconstrictor response to KCl in isolated and pressurized small coronary arteries. These results indicate that RyR-and cADPR-mediated CICR is involved in the control of [Ca 2ϩ ] i in coronary arterial smooth muscles, thereby participating in the vasomotor response in these arteries.
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